September 5, 2016 |
Is removing the prostate through tiny incisions, using a robotic system, better than traditional open-the-abdomen surgery? Prostate cancer specialists have argued about that question for 16 years, ever since U.S. approval of the high-tech, high-cost system made it a coveted commodity for hospitals trying to stay competitive. In July, the Lancet medical journal published an eagerly anticipated Australian clinical trial, the first to randomly assign men to the different methods and compare their outcomes.
August 24, 2016 |
Pharmaceutical giant Pfizer announced Monday that it will buy cancer biotech company Medivation for about $14 billion, adding a leading prostate-cancer drug to its oncology offerings. San Francisco-based Medivation shares were up nearly 20 percent on the news, closing Monday at $80.42 per share. Pfizer will pay $81.50 a share in cash for Medivation, compared with Sanofi S.A.'s offer in April of $52.50 a share. Since then, Merck, AstraZeneca, Celgene, and Gilead Sciences all reportedly had expressed interest in buying the cancer biotech.
August 20, 2016 |
When an influential federal panel recommended in 2012 that doctors omit prostate cancer screening from routine health care, it set off a firestorm. Many men and their doctors seem to have heeded the advice, though the long-term implications won't be clear for a while, a new analysis suggests. The advice of the U.S. Preventive Services Task Force appears to have led to a sizable drop in screening with the PSA blood test, and in diagnosis of early-stage prostate cancer, according to American Cancer Society researchers who have been monitoring the trends.
August 9, 2016 |
Replacing Andre Watts in a high-profile engagement has long given young pianists a career boost. Watts' Aug. 17 cancellation with the Philadelphia Orchestra at the Saratoga (N.Y.) Performing Arts Center, however, comes with extra gravity: The long-admired 70-year-old pianist has prostate cancer. "It's Andre's wish that we be straight about that," said his manager Linda Marder, whose talent roster at CM Artists includes numerous pianists who are guests of the Philadelphia Orchestra. "Men of a certain age have this problem.
July 20, 2016 |
A new study documents a decade-long increase in the number of men who have incurable prostate cancer at their initial diagnosis, an ominous finding that prostate cancer-screening proponents have been predicting. Both screening and diagnosis of early-stage prostate cancer have declined, coinciding with recommendations from an influential government advisory panel. In 2008, the U.S. Preventive Services Task Force said not to do routine PSA blood testing of men over age 74. And in 2012, it said to not screen any men - not even those at high risk - because the harms of unnecessary treatment outweigh the benefits of catching cancer early.
July 9, 2016 |
Men with metastatic prostate cancer have a surprisingly high rate of inherited mutations in DNA-repair genes, suggesting that all men with such advanced prostate cancer should be considered for genetic testing, a new study concludes. Genetic testing is not recommended for men with cancer confined to the prostate - or men whose cancer later spreads - because studies have found less than 5 percent have defective DNA-repair genes. But the prevalence of such defects among men who are initially diagnosed with metastatic prostate cancer has been unclear, according to the new study, published Wednesday in the New England Journal of Medicine by researchers from six leading cancer centers in the United States and Britain.
July 2, 2016 |
Peter A. Brigham, 76, of Wynnewood, a national leader in the field of burn injury care and prevention, died of prostate cancer Wednesday, June 22, at Wesley Enhanced Living Main Line in Media. Mr. Brigham was the founding director of the Philadelphia-based Burn Foundation, which supports burn care centers at area hospitals. He was president of the organization for a quarter-century, from 1979 to 2004, while simultaneously making strides in national burn data collection. He was considered a groundbreaker for his work with the American Burn Association (ABA)
June 27, 2016 |
BUFFALO - Pascal Laberge and his family have been through a tragic year, but the talented right winger had a moment to savor Saturday morning as he hugged his father after learning the Flyers had selected him in the second round of the NHL draft. "My family and I have been through a lot," Laberge said. Last September, his stepmother - a woman Laberge said he "loved dearly" - died of cancer. It wasn't many days later that his father called Laberge and his brothers into their living room and broke down in tears, telling them he had prostate cancer.
June 12, 2016
Q. Should I get screened for prostate cancer? A. Prostate specific antigen, or PSA, testing remains the main screening test for prostate cancer, along with clinical prostate gland examination. PSA is produced by the prostate gland in men; higher levels of PSA may indicate the presence of prostate cancer. But studies also indicate that overdiagnosis and overtreatment of prostate cancer could be a concern, because men often die with and not of prostate cancer. Because we can't yet determine which early-stage prostate cancers can progress to advanced disease and which are slow-growing and can be left untreated, a number of professional organizations recommend "shared decision-making.
May 25, 2016 |
When he was diagnosed with stage-4 prostate cancer in December 2010, Philadelphia Police Officer James Henninger was told he had between six months and two years to live. But that didn't stop the veteran officer from reporting to work every day in Center City's Ninth District, while he received radiation treatment on his lunch break. On Saturday, May 21 - more than five years after his diagnosis - Mr. Henninger, 71, lost his battle with cancer at Crossroads Hospice in Plymouth Meeting, one week before his 50th wedding anniversary.